Page last updated: 2024-09-04

vatalanib and Obesity

vatalanib has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collen, D; Kemp, D; Lijnen, HR; Van Hoef, B1

Other Studies

1 other study(ies) available for vatalanib and Obesity

ArticleYear
Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesity.
    Biochimica et biophysica acta, 2007, Volume: 1770, Issue:9

    Topics: Adipose Tissue; Animals; Dietary Fats; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Obesity; Phthalazines; Pyridines; Receptors, Vascular Endothelial Growth Factor

2007